Search

Susan E Swedo

from Lovettsville, VA
Age ~68

Susan Swedo Phones & Addresses

  • Lovettsville, VA
  • Chicago, IL
  • Lorton, VA
  • Mc Lean, VA
  • 1025 Bellview Pl, Mc Lean, VA 22102

Work

Company: VALID FOR US CIVIL SERVICE EMPLOYEE ON Address: 10 Center Dr, Bethesda, MD 20892 Phones: (301) 496-0207

Education

School / High School: Southern Illinois University At Edwardsville 1980

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Pediatrics, 1985

Specialities

Pediatrics

Professional Records

Medicine Doctors

Susan Swedo Photo 1

Dr. Susan A Swedo, Bethesda MD - MD (Doctor of Medicine)

View page
Specialties:
Pediatrics
Address:
10 Center Dr, Bethesda, MD 20892

VALID FOR US CIVIL SERVICE EMPLOYEE ON
10 Center Dr, Bethesda, MD 20892
(301) 496-0207 (Phone)
Certifications:
Pediatrics, 1985
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Southern Illinois University At Edwardsville
Graduated: 1980
Medical School
Childrens Memorial Hospital
Graduated: 1980
Susan Swedo Photo 2

Susan Anderson Swedo, Bethesda MD

View page
Specialties:
Pediatrics
Work:
National Institute Of Mental Health
10 Center Dr, Bethesda, MD 20892
Education:
Southern Illinois University (1980)

Business Records

Name / Title
Company / Classification
Phones & Addresses
Susan Anderson Swedo
Susan Swedo MD
Pediatrician
10 Ctr Dr, Bethesda, MD 20892
(301) 496-5323

Publications

Isbn (Books And Publications)

It's Not All in Your Head: Now Women Can Discover the Real Causes of Their Most Commonly Misdiagnosed Health Problems

View page
Author

Susan Swedo

ISBN #

0062512870

It's Not All in Your Head: Now Women Can Discover the Real Causes of Their Most Commonly Misdiagnosed Health Problems

View page
Author

Susan Swedo

ISBN #

0062512862

Is It "Just a Phase"?: How to Tell Common Childhood Phases from More Serious Problems

View page
Author

Susan Swedo

ISBN #

0767903919

Wikipedia

Susan Swedo

View page

Susan Swedo is a researcher in the field of pediatrics and neuropsychiatry, and since 1998 has been Chief of the Pediatrics & Developmental Neuroscience ...

Us Patents

Method Of Identifying Persons Susceptible To Autoimmune Neuropsychiatric Disorders

View page
US Patent:
58663479, Feb 2, 1999
Filed:
Apr 8, 1997
Appl. No.:
8/833653
Inventors:
Susan E. Swedo - McLean VA
Henrietta L. Leonard - Providence RI
John B. Zabriskie - New York NY
Assignee:
The United States of America as represented by the Department of Health
and Human Services - Washington DC
International Classification:
G01N 3353
G01N 33564
G01N 33543
G01N 33577
US Classification:
435 724
Abstract:
A method of identifying individuals who have, or who are at risk of developing, autoimmune neuropsychiatric disorders is disclosed. The invented method relies on detection of the B lymphocyte antigen, D8/17. The invented method can conveniently be carried out as a simple blood test.

Method Of Treating Trichotillomania And Onchyphagia

View page
US Patent:
50082620, Apr 16, 1991
Filed:
Apr 19, 1988
Appl. No.:
7/207617
Inventors:
Susan E. Swedo - Lorton VA
Judith L. Rapoport - Washington DC
Henrietta L. Leonard - Washington DC
Assignee:
The United States of America as represented by the Department of Health
and Human Services - Washington DC
International Classification:
A61K 31395
US Classification:
514217
Abstract:
The instant invention is drawn to the use of clomipramine for treating trichotillomania and onchyphagia.

Diagnostic Method For Pediatric Acute-Onset Neuropsychiatric Syndrome (Pans) And Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococci Infection (Pandas)

View page
US Patent:
20160161497, Jun 9, 2016
Filed:
Feb 16, 2016
Appl. No.:
15/045146
Inventors:
Phina Madeleine Cummingham - Oklahoma City OK, US
Craig David Shimasaki - Edmond OK, US
Susan E. Swedo - Mc Lean VA, US
International Classification:
G01N 33/68
Abstract:
The present invention provides a panel of at least five clinical analyses or tests (using serum samples) to determine the risk of pediatric acute-onset neuropsychiatric syndrome (PANS) and/or pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection (PANDAS) in an individual. These include enzyme linked immunosorbent assays (ELISAs) to measure antibody titers against neuronal antigens present in the brain; the neuronal antigens include lysoganglioside, tubulin, dopamine receptor D1, dopamine receptor D2, serotonin receptor 5HT2A, and serotonin receptor 5HT2C. Antibody titers against at least four of these neuronal antigens are required in the present methods; preferably antibody tiers against all of these neuronal antigens are measured. A final assay is used to quantify calcium/calmodulin-dependent protein kinase activity using a neuronal cell line. The results of these analyses or tests are then combined using an algorithm to determine whether a PANS or PANDAS diagnosis is appropriate for the individual. Depending on the diagnosis, an appropriate treatment can be determined.

Diagnostic Method For Pediatric Acute-Onset Neuropsychiatric Syndrome (Pans) And Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococci Infection (Pandas)

View page
US Patent:
20160161498, Jun 9, 2016
Filed:
Jul 2, 2015
Appl. No.:
14/790416
Inventors:
Phina Madeleine Cummingham - Oklahoma City OK, US
Craig David Shimasaki - Edmond OK, US
Susan E. Swedo - McLean VA, US
International Classification:
G01N 33/68
G01N 33/564
Abstract:
The present invention provides a panel of at least five clinical analyses or tests (using serum samples) to determine the risk of pediatric acute-onset neuropsychiatric syndrome (PANS) and/or pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection (PANDAS) in an individual. These include enzyme linked immunosorbent assays (ELISAs) to measure antibody titers against neuronal antigens present in the brain; the neuronal antigens include lysoganglioside, tubulin, dopamine receptor D1, dopamine receptor D2, serotonin receptor 5HT2A, and serotonin receptor 5HT2C. Antibody titers against at least four of these neuronal antigens are required in the present methods; preferably antibody tiers against all of these neuronal antigens are measured. A final assay is used to quantify calcium/calmodulin-dependent protein kinase activity using a neuronal cell line. The results of these analyses or tests are then combined using an algorithm to determine whether a PANS or PANDAS diagnosis is appropriate for the individual. Depending on the diagnosis, an appropriate treatment can be determined.
Susan E Swedo from Lovettsville, VA, age ~68 Get Report